Coherus BioSciences, Inc.
COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)
Last updated:
Abstract:
Provided herein are methods and combination therapies useful for the treatment of non-alcoholic fatty liver diseases (NAFLD). In particular, provided herein are methods and combination therapies for treating NAFLD by administering a combination therapy comprising (a) the compound of Formula (I), or a pharmaceutically acceptable salt or solvate thereof, and (b) an SGLT-2 inhibitor, or a pharmaceutically acceptable salt or solvate thereof, or a GLP-1 receptor agonist, or a pharmaceutically acceptable salt or solvate thereof. Also provided are pharmaceutical compositions and pharmaceutical combinations comprising the compound of Formula (I) and an SGLT-2 inhibitor or a GLP-1 receptor agonist.
Status:
Application
Type:
Utility
Filling date:
27 Dec 2019
Issue date:
23 Jun 2022